The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation.
 
Ronnie Shapira-Frommer
No Relationships to Disclose
 
Amit M. Oza
Consulting or Advisory Role - Amgen; Clovis Oncology; Verastem
Research Funding - AstraZeneca; Immunogen; Immunovaccine; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Susan M. Domchek
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst)
 
Judith Balmaña
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); PharmaMar (Inst)
 
Manish R. Patel
Honoraria - Lilly; Medivation
Speakers' Bureau - Lilly; Medivation
 
Lee-may Chen
Honoraria - Genentech
Consulting or Advisory Role - Genentech
 
Yvette Drew
No Relationships to Disclose
 
Howard A. Burris
No Relationships to Disclose
 
Jacob Korach
No Relationships to Disclose
 
Michael Flynn
Employment - MedImmune
Research Funding - MedImmune
 
Valerie Lydia Bowering
Consulting or Advisory Role - AstraZeneca
 
Mark Aloysuis Morgan
No Relationships to Disclose
 
Simon Paul Watkins
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Dayna Simpson
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Sandra Goble
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Lara Maloney
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Rebecca Sophie Kristeleit
Honoraria - Clovis Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - Clovis Oncology; Novartis
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; PiQuR